Page last updated: 2024-08-23

bm 13505 and Leukocytosis

bm 13505 has been researched along with Leukocytosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ney, P; Schrör, K; Thiemermann, C	1

Other Studies

1 other study(ies) available for bm 13505 and Leukocytosis

Article	Year
The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosis. European journal of pharmacology, 1988, Oct-11, Volume: 155, Issue:1-2 Topics: Adenosine Triphosphate; Animals; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Female; Heart Rate; Hemodynamics; Leukocytosis; Male; Myocardial Contraction; Myocardium; Neutrophils; Oxygen; Phenylacetates; Platelet Count; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxanes	1988

Article

Year

The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosis.

European journal of pharmacology, 1988, Oct-11, Volume: 155, Issue:1-2

Topics: Adenosine Triphosphate; Animals; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Female; Heart Rate; Hemodynamics; Leukocytosis; Male; Myocardial Contraction; Myocardium; Neutrophils; Oxygen; Phenylacetates; Platelet Count; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxanes

1988